Concepedia

Emilie Dejean

ED

Statistics

Publications

5

Citations

328

H-Index

5

Active since

2010

Affiliations

Inserm(Current)

Université Toulouse III - Paul Sabatier

Centre de Recherches en Cancérologie de Toulouse

Centre National de la Recherche Scientifique

Hôpital Purpan

Emilie Dejean is an author at Inserm specializing in medicine, oncology, and oncogenes.

Publications per year

2010–2012

5

Publications

5

MiR-29a down-regulation in ALK-positive anaplastic large cell lymphomas contributes to apoptosis blockade through MCL-1 overexpression

Cécile Desjobert, Marie-Hélène Renalier, Julie Bergalet et al. · Blood · 2011 · 127 citations · Full text

, , +16

Hypoxia-microRNA-16 downregulation induces VEGF expression in anaplastic lymphoma kinase (ALK)-positive anaplastic large-cell lymphomas

Emilie Dejean, Marie-Hélène Renalier, Marianne Foisseau et al. · Leukemia · 2011 · 108 citations

, , +16

Conditional TPM3-ALK and NPM-ALK transgenic mice develop reversible ALK-positive early B-cell lymphoma/leukemia

Sylvie Giuriato, Marianne Foisseau, Emilie Dejean et al. · Blood · 2010 · 33 citations · Full text

, , +11

ALK+ALCLs induce cutaneous, HMGB-1–dependent IL-8/CXCL8 production by keratinocytes through NF-κB activation

Emilie Dejean, Marianne Foisseau, Frédéric Lagarrigue et al. · Blood · 2012 · 32 citations · Full text

, , +14

Inhibition of Rac controls NPM–ALK-dependent lymphoma development and dissemination

Audrey Colomba, Sylvie Giuriato, Emilie Dejean et al. · Blood Cancer Journal · 2011 · 28 citations · Full text

, , +17

1–5 of 5